Sensei Biotherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SNSE and other ETFs, options, and stocks.About SNSE
Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.
CEOJohn K. Celebi
CEOJohn K. Celebi
Employees15
Employees15
HeadquartersRockville, Maryland
HeadquartersRockville, Maryland
Founded1999
Founded1999
Employees15
Employees15
SNSE Key Statistics
Market cap11.50M
Market cap11.50M
Price-Earnings ratio-0.43
Price-Earnings ratio-0.43
Dividend yield—
Dividend yield—
Average volume147.66K
Average volume147.66K
High today$9.12
High today$9.12
Low today$8.20
Low today$8.20
Open price$8.20
Open price$8.20
Volume25.20K
Volume25.20K
52 Week high$18.35
52 Week high$18.35
52 Week low$5.00
52 Week low$5.00
Stock Snapshot
Sensei Biotherapeutics(SNSE) stock is priced at $8.90, giving the company a market capitalization of 11.5M. It carries a P/E multiple of -0.43.
On 2025-12-19, Sensei Biotherapeutics(SNSE) stock traded between a low of $8.20 and a high of $9.12. Shares are currently priced at $8.90, which is +8.5% above the low and -2.4% below the high.
The Sensei Biotherapeutics(SNSE)'s current trading volume is 25.2K, compared to an average daily volume of 147.66K.
During the past year, Sensei Biotherapeutics(SNSE) stock moved between $5.00 at its lowest and $18.35 at its peak.
During the past year, Sensei Biotherapeutics(SNSE) stock moved between $5.00 at its lowest and $18.35 at its peak.
People also own
Based on the portfolios of people who own SNSE. This list is generated using Robinhood data, and it’s not a recommendation.